247 related articles for article (PubMed ID: 29653744)
1. Low expression of B-Cell-Associated protein 31 is associated with unfavorable prognosis in human colorectal cancer.
Ma C; Jin RM; Chen KJ; Hao T; Li BS; Zhao DH; Jiang H
Pathol Res Pract; 2018 May; 214(5):661-666. PubMed ID: 29653744
[TBL] [Abstract][Full Text] [Related]
2. Low expression of B-cell-associated protein 31 in human primary hepatocellular carcinoma correlates with poor prognosis.
Tan N; Liu Q; Liu X; Gong Z; Zeng Y; Pan G; Xu Q; He S
Histopathology; 2016 Jan; 68(2):221-9. PubMed ID: 25980696
[TBL] [Abstract][Full Text] [Related]
3. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
4. Low expression of RASSF10 is associated with poor survival in patients with colorectal cancer.
Wang F; Li P; Feng Y; Hu YL; Liu YF; Guo YB; Jiang XL; Mao QS; Xue WJ
Hum Pathol; 2017 Apr; 62():108-114. PubMed ID: 28041974
[TBL] [Abstract][Full Text] [Related]
5. Expression of pyruvate kinase M2 in human colorectal cancer and its prognostic value.
Cui R; Shi XY
Int J Clin Exp Pathol; 2015; 8(9):11393-9. PubMed ID: 26617865
[TBL] [Abstract][Full Text] [Related]
6. Expression of chemokine receptor CXCR7 in colorectal carcinoma and its prognostic significance.
Yang D; Dai T; Xue L; Liu X; Wu B; Geng J; Mao X; Wang R; Chen L; Chu X
Int J Clin Exp Pathol; 2015; 8(10):13051-8. PubMed ID: 26722500
[TBL] [Abstract][Full Text] [Related]
7. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
8. KIF2A overexpression and its association with clinicopathologic characteristics and unfavorable prognosis in colorectal cancer.
Fan X; Wang X; Zhu H; Wang W; Zhang S; Wang Z
Tumour Biol; 2015 Nov; 36(11):8895-902. PubMed ID: 26070867
[TBL] [Abstract][Full Text] [Related]
9. High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer.
Wang C; Zhou Y; Ruan R; Zheng M; Han W; Liao L
Int J Clin Exp Pathol; 2015; 8(6):7112-21. PubMed ID: 26261604
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic significance of TRAP1 expression in colorectal cancer: a large scale study of human colorectal adenocarcinoma tissues.
Pak MG; Koh HJ; Roh MS
Diagn Pathol; 2017 Jan; 12(1):6. PubMed ID: 28088229
[TBL] [Abstract][Full Text] [Related]
11. Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.
Xu J; Liu Y; Wang X; Huang J; Zhu H; Hu Z; Wang D
Int J Clin Exp Pathol; 2015; 8(3):2909-18. PubMed ID: 26045799
[TBL] [Abstract][Full Text] [Related]
12. Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer.
Zhang BY; Jones JC; Briggler AM; Hubbard JM; Kipp BR; Sargent DJ; Dixon JG; Grothey A
Clin Colorectal Cancer; 2017 Jun; 16(2):124-128. PubMed ID: 27726953
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic target.
Ye L; Lin ST; Mi YS; Liu Y; Ma Y; Sun HM; Peng ZH; Fan JW
Tumour Biol; 2016 Nov; 37(11):14585-14594. PubMed ID: 27614686
[TBL] [Abstract][Full Text] [Related]
14. Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis.
Shigematsu Y; Inamura K; Yamamoto N; Mise Y; Saiura A; Ishikawa Y; Takahashi S; Kanda H
BMC Cancer; 2018 Oct; 18(1):980. PubMed ID: 30326864
[TBL] [Abstract][Full Text] [Related]
15. Association Between Hypoxia-Inducible Factor-2α (HIF-2α) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic Analysis.
Han S; Huang T; Li W; Liu S; Yang W; Shi Q; Li H; Ren J; Hou F
Cell Physiol Biochem; 2018; 48(2):516-527. PubMed ID: 30021192
[TBL] [Abstract][Full Text] [Related]
16. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Zheng HT; Shi DB; Wang YW; Li XX; Xu Y; Tripathi P; Gu WL; Cai GX; Cai SJ
Int J Clin Exp Pathol; 2014; 7(6):3174-81. PubMed ID: 25031737
[TBL] [Abstract][Full Text] [Related]
17. Synergistic role of Caspase-8 and Caspase-3 expressions: Prognostic and predictive biomarkers in colorectal cancer.
Yao Q; Wang W; Jin J; Min K; Yang J; Zhong Y; Xu C; Deng J; Zhou Y
Cancer Biomark; 2018; 21(4):899-908. PubMed ID: 29355114
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of NETO2 expression correlates with tumor progression and poor prognosis in colorectal carcinoma.
Hu L; Chen HY; Cai J; Yang GZ; Feng D; Zhai YX; Gong H; Qi CY; Zhang Y; Fu H; Cai QP; Gao CF
BMC Cancer; 2015 Dec; 15():1006. PubMed ID: 26699544
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylated p38, a negative prognostic biomarker, complements TNM staging prognostication in colorectal cancer.
Fan XJ; Wan XB; Fu XH; Wu PH; Chen DK; Wang PN; Jiang L; Wang DH; Chen ZT; Huang Y; Wang JP; Wang L
Tumour Biol; 2014 Oct; 35(10):10487-95. PubMed ID: 25056534
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer.
Li Y; Liang L; Dai W; Cai G; Xu Y; Li X; Li Q; Cai S
Mol Cancer; 2016 Aug; 15(1):55. PubMed ID: 27552968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]